Cargando…

Remdesivir for COVID-19 in Europe: will it provide value for money?

Detalles Bibliográficos
Autores principales:	Dal-Ré, Rafael, Banzi, Rita, Georgin-Lavialle, Sophie, Porcher, Raphaël, Sofat, Reecha, Zeitlinger, Markus, Rosendaal, Frits R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836228/ https://www.ncbi.nlm.nih.gov/pubmed/33341157 http://dx.doi.org/10.1016/S2213-2600(20)30568-3

Ejemplares similares

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Remdesivir for COVID-19: challenges of underpowered studies
por: Norrie, John David
Publicado: (2020)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Remdesivir saves lives. Were 3 years needed to learn that?
por: Kalil, Andre C
Publicado: (2023)

Impact des maladies auto-immunes/auto-inflammatoires rares et de leur traitement sur la sévérité de l’infection à SARS-CoV-2 : à propos de 691 patients de la cohorte française FAI(2)R
por: Georgin-Lavialle, S.
Publicado: (2020)

Drug and therapeutics committees as guardians of safe and rational medicines use
por: Sofat, Reecha, et al.
Publicado: (2019)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
por: Delplanque, Marion, et al.
Publicado: (2022)

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.
por: Delplanque, Marion, et al.
Publicado: (2022)

COVID and the convergence of three crises in Europe
por: Bozorgmehr, Kayvan, et al.
Publicado: (2020)

Reflections on travel-associated infections in Europe
por: Petersen, Eskild, et al.
Publicado: (2015)

The personal economic burden of dementia in Europe
por: Jönsson, Linus
Publicado: (2022)

No time for complacency on COVID-19 in Europe
por: Flahault, Antoine, et al.
Publicado: (2023)

Offline: Europe and COVID-19—struggling with tragedy
por: Horton, Richard
Publicado: (2020)

Closing the gap for drowning prevention across Europe
por: Peden, Amy E, et al.
Publicado: (2022)

The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review
por: Hentgen, Véronique, et al.
Publicado: (2020)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

Maximizing the GDPR potential for data transfers: first in Europe
por: Bentzen, Heidi Beate, et al.
Publicado: (2023)

High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries
por: Dal-Ré, Rafael, et al.
Publicado: (2022)

Tackling the re-emergence of wheat stem rust in Western Europe
por: Saunders, Diane G. O., et al.
Publicado: (2019)

Europe’s renewable energy directive poised to harm global forests
por: Searchinger, Timothy D., et al.
Publicado: (2018)

COVID-19 in Europe: new challenges for addressing vaccine hesitancy
por: Karafillakis, Emilie, et al.
Publicado: (2022)

First detection of porcine circovirus 4 (PCV-4) in Europe
por: Holgado-Martín, Rocío, et al.
Publicado: (2023)

Money, manpower missing from Europe's new agency
por: Vermij, Peter
Publicado: (2005)

The origins of money: Calculation of similarity indexes demonstrates the earliest development of commodity money in prehistoric Central Europe
por: Kuijpers, Maikel H. G., et al.
Publicado: (2021)

The burden of young people's mental health conditions in Europe: No cause for complacency
por: Neufeld, Sharon A.S.
Publicado: (2022)

Understanding and addressing long-COVID among migrants and ethnic minorities in Europe
por: Norredam, Marie, et al.
Publicado: (2022)

Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
por: Peng, Ling, et al.
Publicado: (2020)

Towards further harmonization of a glossary for exposure science—an ISES Europe statement
por: Heinemeyer, Gerhard, et al.
Publicado: (2021)

Cardiovascular diseases and health inequalities in Europe—a pressing public health challenge
por: Toft Sørensen, Henrik, et al.
Publicado: (2023)

Managing bacterial sexually transmitted infections (STIs) and preventing HIV/STIs in Europe
por: Bébéar, Cécile, et al.
Publicado: (2023)

Approaching unsafe limits: climate-related health inequities within and beyond Europe
por: van Daalen, Kim R., et al.
Publicado: (2023)

Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression
por: Moura, Daniela Silva, et al.
Publicado: (2012)

Intravascular lymphoma presenting as a specific pulmonary embolism and acute respiratory failure: a case report
por: Georgin-Lavialle, Sophie, et al.
Publicado: (2009)

Thank you to The LANCET Regional Health - Europe’s clinical and statistical peer reviewers in 2021
Publicado: (2022)

Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe
por: Scarpa, Maurizio, et al.
Publicado: (2022)

Thank you to The Lancet Regional Health - Europe's clinical and statistical peer reviewers in 2022
Publicado: (2023)

Antimicrobial Stewardship Initiatives Throughout Europe: Proven Value for Money
por: Oberjé, Edwin J.M., et al.
Publicado: (2017)

Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies
por: Garattini, Silvio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dgdufl9mmnir5aoq8c20pkn22k